Provided By PR Newswire
Last update: Jul 31, 2025
NEW YORK, July 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company") (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:EWTX (10/20/2025, 3:15:59 PM)
15.79
+0.73 (+4.85%)
Find more stocks in the Stock Screener


